CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- 4 Other disposition President and CEO disposed of 20,000 shares (other)
- 4 Exercise or conversion Chief Financial Officer acquired 5,834 shares (option exercise)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Shares withheld for taxes President and CEO gave up 2,055 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 10,075 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 87,801 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
- 4 Shares withheld for taxes President and CEO gave up 16,115 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,567 shares at $7.79 ($19,997)
- 4 Open-market buy Director bought 5,000 shares at $7.95 ($39,750)
Page 3 of 23 · 459 filings